4//SEC Filing
O'Loughlin Steve 4
Accession 0001213900-18-002726
CIK 0001388320other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:20 PM ET
Size
9.1 KB
Accession
0001213900-18-002726
Insider Transaction Report
Form 4
O'Loughlin Steve
Chief Financial Officer
Transactions
- Other
Common Stock
2018-03-06$0.50/sh+10,000$5,000→ 13,500 total - Other
Series B Warrants
2018-03-06$0.50/sh+7,500$3,750→ 7,500 totalExercise: $0.70From: 2018-03-06Exp: 2020-09-06→ Common Stock (7,500 underlying) - Other
Series A Warrants
2018-03-06$0.50/sh+2,500$1,250→ 2,500 totalExercise: $0.60From: 2018-03-06Exp: 2019-03-06→ Common Stock (2,500 underlying)
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001615840
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:20 PM ET
- Size
- 9.1 KB